Form 4 Filing for Replimune Group, Inc. - Joseph P. Slattery

This Form 4 filing reports the acquisition of 44,500 stock options by Joseph P. Slattery, a director at Replimune Group, Inc. The options, with an exercise price of $7.61, were granted on April 1, 2026, and are set to expire on April 1, 2036. The underlying securities are 44,500 shares of Common Stock. These options vest entirely on April 1, 2027. The filing was submitted late due to an inadvertent administrative error. Mr. Slattery holds these options directly.